Springfield declares itself the world's Cashew Chicken Capital
SPRINGFIELD, Mo. – Springfield convention and visitors organization 'Visit Springfield' is declaring the city the 'Cashew Chicken Capital of the World' as it kicks off it's second annual event dedicated to the dish.
Yes, the declaration made on June 2, 2025 is a promotion, but there is some truth behind Springfield's most well-known dish.
According to a release from Visit Springfield, starting in June 2025, the Springfield Cashew Chicken Trail officially launched its second season, inviting food lovers to indulge in the dish that helped put Springfield on the culinary map.
Previous coverage: Cashew Chicken could become Missouri's official dish
Cashew Chicken was first created in 1963 when David Leong was looking for a way to better connect with Springfield customers eating at his Chinese restaurant.
By frying chicken chunks and drizzling a concoction of Chinese oyster sauce, cashews, and chopped green onions, Leong was successful in finding the right combination for southwest Missourians taste buds.
'Soon, versions of 'Springfield-Style Cashew Chicken' appeared on menus coast to coast and even around the world,' states Visit Springfield in a article published on the history in March, 2017.
You can find out more about the history of Springfield's famous Cashew Chicken by watching the video above, or by reading Visit Springfield's full history.
Previous coverage: Springfield's first Cashew Chicken Trail
The Cashew Chicken Trail is put on by Visit Springfield and features participating restaurants across the city by offering foodies the chance to sample a wide variety of takes on the classic.
This season's trail includes:
A brand-new, limited-edition Cashew Chicken Trail T-shirt for those who complete the challenge and earn enough points.
Several new restaurants added to the lineup, expanding the trail with even more local flavor and creativity.
Several new cashew chicken-inspired dishes such as cashew chicken pizza, wings, salad, and more that local restaurants have made their own.
Participants can sign up starting June 1 and begin earning points by checking in at participating restaurants and trying their featured dishes. The more stops you make, the more points you earn, and the closer you get to tasty rewards.
To sign up and get started on the trail, visit springfieldmo.org/cashewchicken to learn more.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Trump's Late-Night Lament Over Xi Deepens Impasse in Trade Fight
(Bloomberg) -- President Donald Trump is positioning a personal discussion with his Chinese counterpart as the key to preventing the world's largest economies from spiraling deeper into their trade and technology fight. The Global Struggle to Build Safer Cars At London's New Design Museum, Visitors Get Hands-On Access ICE Moves to DNA-Test Families Targeted for Deportation with New Contract LA City Council Passes Budget That Trims Police, Fire Spending NYC Residents Want Safer Streets, Cheaper Housing, Survey Says But Chinese leader Xi Jinping is making clear that a phone call doesn't come without a price — a resolute stand so far that's apparently keeping Trump up late into the night. 'I like President XI of China, always have, and always will, but he is VERY TOUGH, AND EXTREMELY HARD TO MAKE A DEAL WITH!!!' Trump posted on Truth Social at around 2:17 a.m. Washington time. His complaint came after a flurry of US officials claimed this week the two men were set to speak. Exactly what the Chinese are asking the White House to relinquish in order to secure the one-on-one remains unclear. But the US president's unanswered pleas are looking more like a standoff without an off ramp. Beijing, meanwhile, is making overtures in the direction of Europe, which is engaged in its own tariff dispute with Trump. 'If China doesn't want a call, it could be that they don't intend to comply or are intentionally holding their cards for the time being,' said Kelly Ann Shaw, a partner at Akin Gump and former senior adviser to Trump during his first term. 'If there isn't a call, I would expect further escalation in the bilateral relationship before things de-escalate again.' At the heart of the stalemate is a mismatch in negotiating styles that, if it continues, threatens to derail the bilateral relationship. While Trump wants to hash things out with his counterpart, Chinese officials are reluctant to commit before working out deliverables at lower levels. Oval Office showdowns with the leaders of South Africa and Ukraine in recent weeks have likely offered little reassurance to Beijing to accept Trump's terms. A 'Disconnect' 'There's a fundamental disconnect here,' former acting White House Chief of Staff Mick Mulvaney told Bloomberg Television on Tuesday. 'Trump wants to talk at the very highest levels. That's not always how the Chinese want to do business.' While it isn't impossible for the US and China to strike a deal, expectations for what it would entail look out of sync. Policymakers in Beijing want to have broader access to high-end US chips, essentially for AI and military advancement, as well as the opportunity for more Chinese investment in the US. Beijing could be open to buying more US agricultural products, too. Rolling back sweeping controls on cutting-edge technology expanded under Joe Biden would be politically toxic in Washington, where there's rare consensus among Democrats and Republicans that China poses a national security threat. Officials in Washington also believe Beijing has been dumping goods on the US for decades, threatening American jobs and industry, and are seeking major concessions. That both sides are talking past each other has become evident in the confusion over China's position on rare earths — metals that are core to America's national-security supply chains and automakers in particular. Trump and his team have accused Beijing of breaking the trade agreement announced in mid-May, where both countries significantly lowered tariffs and China agreed to remove other retaliatory measures it imposed in response to earlier duty hikes. In Washington's view, that meant China would immediately grant licenses to export rare earths to American companies that had been cut off. Stalling for Time US Trade Representative Jamieson Greer said China has slow-walked the process. Companies that are reliant on the inputs are feeling the supply squeeze, with some temporarily shuttering production. From Beijing's perspective, it's following procedure on a license system that exports to all nations must follow. As tensions over such shipments grow, the Trump administration has continued to impose restrictions on chip technology and exports of jet engine parts to China. Beijing publicly criticized the moves and, according to the Trump team, continued choking off critical minerals supplies to American companies. While giving Trump the cold shoulder, China is tilting its attention toward Europe, where it sees an opening for deeper trade ties after Trump hit the European Union with tariffs and threatened steeper ones. In anticipation of the EU-China summit in late July in Beijing, Europe's trade chief Maros Sefcovic on Tuesday met Chinese Commerce Minister Wang Wentao in Paris. Ahead of next month's summit, China is considering placing an order for hundreds of Airbus SE aircraft as soon as next month to celebrate the economies' long-term ties, Bloomberg News reported. That represents another blow to Boeing Co., which hasn't won a major order from China since at least 2017 due to the trade tensions and other issues. It all stands in contrast to Trump's first trade offensive against China, when it took just 10 weeks for China to announce Xi would fly to Mar-a-Lago for talks with the US. The result was a so-called phase one trade deal aimed at boosting Chinese purchases of American products — an agreement that went dormant during the Biden administration. This time around, ties have derailed much more quickly — despite Chinese efforts to steady things. January Call Just before Trump's most recent inauguration, Xi called Trump and told the incoming leader he was hoping for a good start to US-China ties, with both sides agreeing to stay in touch. Days later, Trump began targeting fentanyl cooperation, attacking a relatively bright spot in bilateral ties where Beijing has said the US owes it a 'big thank you' for efforts to curtail smuggling. China has repeatedly pointed to demand from Americans as the root cause of fentanyl abuse. Trump followed up with a 20% tariff, setting off tit-for-tat rounds of levies that essentially imposed a trade embargo on the two nations. A US federal court ruled Trump's duties were illegal, sapping the president of leverage, but the order was put on hold as a higher court considers an appeal. Also playing into Xi's reluctance is the fact China is in a stronger position now than in the last trade war to weather Trump's unpredictability. The world's No. 2 economy has been diversifying beyond the US market, its people are relatively united in the face of Trump's threats, and the US is alienating friends and foes alike with its overhaul of economic and defense policy. 'One problem is that Trump is trying to use deal-making to normalize trade aggression,' said Josef Gregory Mahoney, a professor of international relations at Shanghai's East China Normal University. 'Another issue is that he remains an opportunist, and even when deals are struck you can't count on him to keep them, or the next administration.' YouTube Is Swallowing TV Whole, and It's Coming for the Sitcom Is Elon Musk's Political Capital Spent? Millions of Americans Are Obsessed With This Japanese Barbecue Sauce Cavs Owner Dan Gilbert Wants to Donate His Billions—and Walk Again Trump Considers Deporting Migrants to Rwanda After the UK Decides Not To ©2025 Bloomberg L.P.
Yahoo
an hour ago
- Yahoo
Helius Medical Technologies, Inc. Compliant with Nasdaq Bid Price Rule Listing Criteria
Company previously granted extension until June 30, 2025 to regain compliance with Nasdaq's Equity Rule requirement NEWTOWN, Pa., June 04, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) ('Helius' or the 'Company'), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that on June 3, 2025, Helius received formal notice from the Nasdaq Hearings Panel of The Nasdaq Stock Market LLC (the 'Panel') indicating that Helius has evidenced full compliance with the minimum bid price requirement set forth Listing Rules 5550(a)(2) (the 'Bid Price Rule'). The Panel further reminded the Company that it is also required to regain compliance with the equity requirement in Listing Rule 5550(b)(1) (the 'Equity Rule') by June 30, 2025 under the extension previously granted by the Panel. Accordingly, the Nasdaq Listing Qualifications hearing process will remain open until the Company has demonstrated compliance with all of The Nasdaq Stock Market's continued listing requirements. About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain's ability to engage physiologic compensatory mechanisms and promote neuroplasticity, improving the lives of people dealing with neurologic diseases. The Company's first commercial product is the Portable Neuromodulation Stimulator (PoNS®). For more information about PoNS or Helius Medical Technologies, visit Cautionary Disclaimer Statement Certain statements in this news release are not based on historical facts and constitute forward-looking statements or forward-looking information within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and Canadian securities laws. All statements other than statements of historical fact included in this news release are forward-looking statements that involve risks and uncertainties. Forward-looking statements are often identified by terms such as 'believe,' 'expect,' 'continue,' 'will,' 'goal,' 'aim' and similar expressions. Such forward-looking statements include, among others, but are not limited to, statements regarding the Company's ability to achieve and maintain compliance with the Nasdaq listing rules. The reader is cautioned not to place undue reliance on any forward-looking statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company assumes no obligation to update any forward-looking statement or to update the reasons why actual results could differ from such statements except to the extent required by law. Investor Relations Contact Philip Trip TaylorGilmartin Groupinvestorrelations@
Yahoo
an hour ago
- Yahoo
Mindset Medical Announces FDA Clearance for its Contactless Respiratory Rate Measurement Device
PHOENIX, June 4, 2025 /PRNewswire/ -- Mindset Medical, Inc. ("Mindset Medical" or the "Company"), a digital health company, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its latest contactless vital sign monitoring solution. The Informed Vital Core (IVC) App is a software-only medical device that measures respiratory rate through smartphones, tablets, or laptop cameras. This milestone marks Mindset Medical's second FDA clearance in less than a year, building on the success of its previously cleared pulse rate measurement device on November 18, 2024. With these clearances, Mindset Medical is closer to transforming the delivery of care with innovative telehealth technology. Mindset Medical can now offer another solution for healthcare providers to gather physiological information from their patients without needing physical contact or dedicated hardware. Software on phones, tablets, and laptops can easily be deployed in clinical and outpatient facilities, remote care environments, long-term care settings, or the patient's home. Telemedicine skyrocketed due to COVID-19, as many barriers to adoption were removed, allowing video conferencing to become routine. "Video alone is not enough. Patients and providers deserve virtual services with fewer barriers and limitations because we are all patients at the end of the day. The next step is purpose-built virtual health offerings that can legitimately provide brick-and-mortar experiences. Virtual healthcare remains a permanent fixture moving forward, and we have only scratched the surface of how we use technology to address shortcomings with the health system."-- Mitch Foster, Chairman and CEO of Mindset Medical. Mindset Medical envisions a future where vital signs and diagnoses can be captured with nothing more than everyday devices. This will help bridge gaps in access to healthcare, reduce the burden on providers, and improve chances for earlier intervention. The company continues developing its platform to include additional vital sign measurements, working closely with clinicians and patients to ensure each new feature meets their needs. About Mindset Medical Mindset Medical, Inc. ( headquartered in Phoenix, AZ, was formed by several members of Excelsius Surgical, a robotic surgical platform. Recently, Mindset Medical has developed proprietary signal-processing algorithms that extract health measurements from video. Combined with AI technology for advanced image analysis and facial recognition, these algorithms transform patients' smartphones into contactless vital sign measurement devices. Mindset Medical utilizes secure and encrypted links delivered to patients from healthcare providers to collect up-to-the-minute patient data and accurate remote physiological measurements. Contact For media, sales, or investor inquiries, please email 396163@ or 396163@ We can also be reached at 480.269.0859. HASHTAGS#healthcare #telehealth #healthequity #vitals #physiological SOCIAL MEDIA PROFILESLinkedin: View original content: SOURCE Mindset Medical, Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
